CoChat

Low Estradiol Concentrations in Men With Subnormal Testosterone Concentrations and Type 2 Diabetes

Open access
Dhindsa, Sandeep, Furlanetto, Richard, Vora, Mehul, Ghanim, Husam, Chaudhuri, Ajay, Dandona, Paresh · 2011 · Diabetes Care
Cited by 127

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: It has been suggested that the high prevalence of subnormal free testosterone concentrations, along with low or inappropriately normal gonadotropins in men with type 2 diabetes, may be the result of an increase in plasma estradiol concentrations secondary to an increase in aromatase activity in the adipose tissue that leads to the suppression of the hypothalamo-hypophyseal-gonadal axis. RESEARCH DESIGN AND METHODS: To investigate this hypothesis, plasma estradiol, testosterone, leutinizing hormone, follicle-stimulating hormone, and sex hormone–binding globulin (SHBG) concentrations were measured in fasting blood samples of 240 men with type 2 diabetes. Free estradiol concentrations were either calculated (n = 198) using total estradiol and SHBG measured by immunoassay or directly measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) and equilibrium dialysis (n = 102). RESULTS: The calculated free estradiol concentration in men with subnormal free testosterone concentrations was lower than that in men with normal free testosterone concentrations (median 0.047 vs. 0.063 ng/dL, P < 0.001). Directly measured (LC-MS/MS) free estradiol concentrations were also lower in men with subnormal free testosterone concentrations (median 0.025 vs. 0.045 ng/dL, P = 0.008). Free estradiol concentrations were directly related to free testosterone but not to BMI or age. CONCLUSIONS: These data show that the suppression of the hypothalamo-hypophyseal-gonadal axis in patients with subnormal free testosterone concentrations and type 2 diabetes is not associated with increased estradiol concentrations. The pathogenesis of subnormal free testosterone concentrations in type 2 diabetes needs to be investigated further.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc11-0208

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 11

  1. Chandel, 2008, Testosterone concentration in young patients with diabetes, Diabetes Care, 31, 2013, 10.2337/dc08-0851 · DOI · Paper page
  2. Hofstra, 2008, High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment, Neth J Med, 66, 103
  3. Wake, 2007, Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity, Clin Endocrinol (Oxf), 66, 440, 10.1111/j.1365-2265.2007.02755.x · DOI · Paper page
  4. Pitteloud, 2008, Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men, J Clin Endocrinol Metab, 93, 784, 10.1210/jc.2007-2156 · DOI · Paper page
  5. Salameh, 2010, Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges, Steroids, 75, 169, 10.1016/j.steroids.2009.11.004 · DOI
  6. van den Beld, 2000, Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men, J Clin Endocrinol Metab, 85, 3276
  7. Beal, 2001, Ways to fit a PK model with some data below the quantification limit, J Pharmacokinet Pharmacodyn, 28, 481, 10.1023/A:1012299115260 · DOI · Paper page
  8. Rinaldi, 2002, Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations, Cancer Epidemiol Biomarkers Prev, 11, 1065
  9. Schneider, 1979, Increased estrogen production in obese men, J Clin Endocrinol Metab, 48, 633, 10.1210/jcem-48-4-633 · DOI · Paper page
  10. Salvi, 2006, Gonadotropin-releasing hormone-expressing neurons immortalized conditionally are activated by insulin: implication of the mitogen-activated protein kinase pathway, Endocrinology, 147, 816, 10.1210/en.2005-0728 · DOI · Paper page
  11. Bhatia, 2006, Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes, Diabetes Care, 29, 2289, 10.2337/dc06-0637 · DOI · Paper page

Cited by

See all 127

Metadata

Authors
Dhindsa, S., Furlanetto, R., Vora, M., Ghanim, H., Chaudhuri, A., & Dandona, P.
Venue
Diabetes Care
Published
2011-07-16
Volume
34
Issue
8
Pages
1854-1859
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2149753216
Cited by
127
References
14
FWCI
4.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.